Phaos Technology Holdings (Cayman) (POAS) Liabilities and Shareholders Equity (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Liabilities and Shareholders Equity of $982376.0 for Q4 2025, down 32.1% on a QoQ basis from $1.4 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $982376.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | 982,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 982,376.00 |
| Apr 30, 2025 | 1.45 Mn |
| Apr 30, 2024 | 3.85 Mn |